Focus
Drug Discovery Investors: Angels and VC Firms
The RaiseHunt database lists 4,683 Drug Discovery investors: 239 angel investors and 4,444 people at 1,313 firms. Most list Seed and Series A among their stages; the largest hubs are New York, San Francisco and Boston.
Strongest in New York, San Francisco and Boston
- 4,683
- Drug Discovery investors
- 239
- Angel investors
- 4,444
- People at VC/PE firms
- 1,313
- Firms tagged
Skip the browsing. Let AI find your ideal investors in one minute.
Paste your startup website and AI picks your best-fit investors out of 135,000+ profiles.
4,683 Drug Discovery investors
Showing 401-420
| Investor | Location | Type | Markets | Contact | Actions |
|---|---|---|---|---|---|
 Philipp Bräuer Vice President at Eqt Life Sciences | Munich, Germany | Private equityVenture capital | Healthcare | View profile | |
 Takuro Yamazaki Manager of Investment department at SBI Investment | Tokyo, Japan | Private equityVenture capital | AIHardware | View profile | |
 Siobhan Clarke Non Executive Director & Investment Committee Member at QUBIS | Manchester, United Kingdom | AcceleratorCorporate VC | AIClimate | View profile | |
 Pete Sonsini Co-founder and General Partner at Laude Ventures | Menlo Park, United States | Corporate VCVenture capital | AICommerce | View profile | |
 Roger Kitterman Managing Partner at Mass General Brigham | Brookline, United States | Corporate VCSyndicate / Angel group | AIHealthcare | View profile | |
 Genghis Lloyd-Harris Investor-In-Residence at Cancer Research Horizons | London, United Kingdom | AcceleratorCorporate VC | AIEducation | View profile | |
 Alex Shubat Member at J-Angels | San Francisco, United States | AcceleratorSyndicate / Angel group | AIConsumer | View profile | |
 Cassie Young Partner at Primary Venture Partners | New York, United States | Family OfficeGovernment-backed | AICommerce | View profile | |
 Johannes Göppinger Investor at CSL | Zürich, Switzerland | Corporate VC | Healthcare | View profile | |
 Anna Katharina Traunbauer Venture Fellow at MPM BioImpact | United States | Private equityVenture capital | Healthcare | View profile | |
 Jordan Barbakow Investor at SDS Capital Group | West Hollywood, United States | Private equityVenture debt | FinTechHealthcare | View profile | |
 Donghong wu Investor at Witruth Capital | Beijing, China | Family OfficePrivate equity | Healthcare | View profile | |
 Natasha Jain Investor at LVX | Thane, India | Syndicate / Angel groupVenture capital | HealthcareSaaS | View profile | |
 Deepa Rao Investment Associate at Engine Ventures | Cambridge, United States | Venture capital | AIClimate | View profile | |
 Spoorthi Devaraja Setty Vice President at LVX | Bengaluru, India | Syndicate / Angel groupVenture capital | HealthcareSaaS | View profile | |
 Campbell Wilson Investor at Frontier Ip Group | Prestbury, United Kingdom | Private equityVenture capital | AIClimate | View profile | |
 David Neary Investor at Morgan Stanley | San Francisco, United States | Corporate VCPrivate equity | FinTechHardware | View profile | |
 Mazyar Ghaffari Affiliated at Novateur Ventures | Sydney, Australia | AcceleratorVenture capital | Healthcare | View profile | |
 Smit Mehta Investment Associate at Calculus Capital | Mumbai, India | Venture capital | ConsumerFinTech | View profile | |
 Charlie Vleck Investor at Wellcome Trust | United Kingdom | Government-backed | AIHealthcare | View profile |
Data: RaiseHunt investor dataset · Snapshot 27 August 2026 · How this data is built · Report a correction or request removal